Cargando…

Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children and adults. This study examined the relationship between hepatic nuclear receptor (NR) expression and histologic features of NAFLD. Drugs targeting a variety of NRs for nonalcoholic steatohepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbel, Erin E., Lavine, Joel E., Downes, Michael, Van Natta, Mark, Yu, Ruth, Schwimmer, Jeffrey B., Behling, Cynthia, Brunt, Elizabeth M., Tonascia, James, Evans, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167075/ https://www.ncbi.nlm.nih.gov/pubmed/30288476 http://dx.doi.org/10.1002/hep4.1232

Ejemplares similares

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease
por: Schwimmer, Jeffrey B., et al.
Publicado: (2014)

The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023)

Association between cytokines and liver histology in children with nonalcoholic fatty liver disease
por: Perito, Emily R., et al.
Publicado: (2017)

Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease
por: Vittorio, Jennifer, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation
por: Brunt, Elizabeth M.
Publicado: (2016)

Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease
por: Wattacheril, Julia, et al.
Publicado: (2018)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Randomized placebo‐controlled trial of losartan for pediatric NAFLD
por: Vos, Miriam B., et al.
Publicado: (2022)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Nobili, Valerio, et al.
Publicado: (2014)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation
por: Brunt, Elizabeth M.
Publicado: (2017)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease
por: Dichtel, Laura E, et al.
Publicado: (2017)

Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease
por: Sharpton, Suzanne R., et al.
Publicado: (2021)

The Effect of Weight Loss on Pediatric Nonalcoholic Fatty Liver Disease
por: St-Jules, David E., et al.
Publicado: (2013)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
por: Sanyal, Arun, et al.
Publicado: (2023)

The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
por: Ryan, Jamie L., et al.
Publicado: (2022)

Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2014)

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease
por: Khodadoostan, Mahsa, et al.
Publicado: (2017)

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease
por: Sonmez, Alper, et al.
Publicado: (2021)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
por: Jamshidi, Neema, et al.
Publicado: (2023)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study
por: Loomba, Rohit, et al.
Publicado: (2014)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
por: Soon, Gwyneth, et al.
Publicado: (2021)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease
por: Powell, Nicholas R., et al.
Publicado: (2023)

Clinico‐histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease
por: Fujiwara, Naoto, et al.
Publicado: (2023)

Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
por: Jin, Ran, et al.
Publicado: (2014)

The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease
por: Cho, Taeshik, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

2464: Phenotypic characteristics of pediatric nonalcoholic fatty liver disease
por: Dowla, Shima, et al.
Publicado: (2018)

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics
por: Farías, Camila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glasbi864bg4q46lvs5tng6p4d